Prospecto: information for the user
Ramipril/Hidroclorotiazida TecniGen 5 mg/25 mg tablets EFG
Ramipril / Hidroclorotiazida
Read this prospect carefully before starting to take the medicine, as it contains important information for you.
1.What is Ramipril/Hidroclorotiazida TecniGen and for what it is used
2.What you need to know before starting to take Ramipril/Hidroclorotiazida TecniGen
3.How to take Ramipril/Hidroclorotiazida TecniGen
4.Possible adverse effects
Ramipril/Hidroclorotiazida TecniGen is a combination of two medications called ramipril and hidroclorotiazida.
Ramipril belongs to a group of medications called angiotensin-converting enzyme (ACE) inhibitors. It works as follows:
Hidroclorotiazida belongs to a group of medications called "thiazide diuretics" (diuretics are also known as "urine tablets"). It works by increasing the amount of water (urine) that is eliminated, which reduces blood pressure.
Ramipril/Hidroclorotiazida TecniGen is used to treat high blood pressure. The two active ingredients it contains work together to reduce blood pressure. They are used together when treatment with only one of them does not provide adequate control of blood pressure
Do not take Ramipril/Hidroclorotiazida TecniGen
The symptoms of an allergic reaction may include skin rash, difficulty swallowing or breathing, swelling of lips, face, throat, or tongue
Do not take Ramipril/Hidroclorotiazida TecniGen if any of the above conditions apply to you.
If you are unsure, speak with your doctor before taking Ramipril/Hidroclorotiazida TecniGen.
Warnings and precautions
Consult with your doctor or pharmacist before starting to take Ramipril/Hidroclorotiazida TecniGen:
Your doctor may check your renal function, blood pressure, and the amount of electrolytes (e.g. potassium) in your blood at regular intervals.
See also the information under the heading “Taking Ramipril/Hidroclorotiazida TecniGen with other medicines”
Pediatric population:
Ramipril/Hidroclorotiazida TecniGen is not recommended for use in children and adolescents under 18 years of age because it has never been used in these age groups.
If any of the above conditions apply to you (or you are unsure), speak with your doctor before taking Ramipril/Hidroclorotiazida TecniGen.
Taking Ramipril/Hidroclorotiazida TecniGen with other medicines:
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication. Ramipril/Hidroclorotiazida TecniGen may affect how some other medicines work. Similarly, some medicines may affect how Ramipril/Hidroclorotiazida TecniGen works.
Inform your doctor if you have taken or are taking any of the following medicines, which may make Ramipril/Hidroclorotiazida TecniGen work less effectively:
Inform your doctor if you are taking any of the following medicines, which may increase the risk of side effects if taken with Ramipril/Hidroclorotiazida TecniGen:
Inform your doctor if you are taking any of the following medicines, which may be affected by Ramipril/Hidroclorotiazida TecniGen:
If any of the above conditions apply to you (or you are unsure), consult your doctor before taking Ramipril/Hidroclorotiazida TecniGen.
Your doctor may need to change your dose and/or take other precautions:
If you are taking an angiotensin II receptor blocker (ARA II) or aliskireno (see information in the section “Do not take Ramipril/Hidroclorotiazida TecniGen” and “Warnings and precautions”)
Tests
Check with your doctor or pharmacist before taking your medicine:
Taking Ramipril/Hidroclorotiazida TecniGen with food, drinks, and alcohol:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medicine.
Do not take Ramipril/Hidroclorotiazida TecniGen in the first 12 weeks of pregnancy, and do not take it in any case after week 13, as its use during pregnancy may be potentially harmful to the baby.
If you become pregnant while taking Ramipril/Hidroclorotiazida TecniGen, inform your doctor immediately. A change to an alternative suitable treatment should be made if you plan to become pregnant.
Do not use Ramipril/Hidroclorotiazida TecniGen if you are breastfeeding.
Driving and operating machinery:
You may feel dizzy while taking Ramipril/Hidroclorotiazida TecniGen, which is more likely to occur when starting to take Ramipril/Hidroclorotiazida TecniGen or starting a higher dose. If you felt dizzy, do not drive or operate tools or machinery.
Ramipril/Hidroclorotiazida TecniGen contains lactose.
If your doctor has told you that you have a certain sugar intolerance, consult with them before taking this medicine.
Ramipril/Hidroclorotiazida TecniGen contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is, essentially “sodium-free”.
Follow exactly the administration instructions for Ramipril/Hidroclorotiazida TecniGen as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Medication Taking
How Much Medication to Take
Hypertension Treatment
Your doctor will adjust the amount you should take until your blood pressure is under control.
Senior Patients
Your doctor will reduce the initial dose and adjust the treatment more slowly.
If You Take More Ramipril/Hidroclorotiazida TecniGen Than You Should
Consult your doctor immediately or go to the nearest hospital emergency department. Do not drive to the hospital: ask someone to take you or call an ambulance. Bring the medication packaging with you so your doctor knows what you have taken.
You can also call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount taken.
If You Forget to Take Ramipril/Hidroclorotiazida TecniGen
If you have any other questions about using this medication, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can causeside effects, although not everyone will experience them.
Stop taking Ramipril/Hidroclorotiazida TecniGen and consult your doctor immediately if you notice any of the following serious side effects. You may need urgent medical treatment:
Inform your doctor immediately if you experience:
Other side effects may be:
Inform your doctor if any of the following side effects worsen or last more than a few days:.
Frequent(affect less than 1 in 10 patients)
Rare(affect less than 1 in 100 patients)
Very rare (affect less than 1 in 10,000 patients)
Frequency not known(the frequency cannot be estimated with the available data)
Other side effects observed:
Inform your doctor if any of the following side effects worsen or last more than a few days.
Communication of side effects:
If you experience any type of side effect, consult your doctor or pharmacist or nurse, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es.
By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medicationafter the expiration date that appears on the packaging after “CAD.”. The expiration date is the last day of the month indicated.
Do not store above25°C. Store in the original packaging to protect the product from moisture.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection pointat the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.
Composition of Ramipril/Hidroclorotiazida TecniGen
The active principles are ramipril and hidroclorotiazida.
One tablet contains5 mg of ramipril and 25 mg of hidroclorotiazida
The other components (excipients) are lactose monohydrate, hypromellose(E464), crospovidone (E1202), microcrystalline cellulose and sodium fumarate stearate.
Appearance of the product and contents of the packaging
Ramipril/Hidroclorotiazida tablets of5/25 mg: White tablets with a modified capsule shape. With a square inscription on both sides, with “5” and "25” on each side of the square on one side.
The tablets are presented in a blister pack of 7, 10, 14, 20, 28, 50, 98, 100, 300 or 2x14 tablets. Not all presentations may be marketed.
Holder ofthe Marketing Authorization and responsible for Manufacturing
Holder of the Marketing Authorization:
Tecnimede España Industria Farmacéutica, S.A.
Avda. de Bruselas, 13, 3rd floor. Edificio América. Polígono Arroyo de la Vega,
28108 Alcobendas (Madrid) SPAIN
Responsible for manufacturing:
Atlantic Pharma Produções Farmacêuticas, S.A.
Rua da Tapada Grande, n.º 2, Abrunheira, 2710-089 Sintra,
Portugal
This medicine is authorized in Portugal under the name ofRamipril/Hidroclorotiazida Romazide 5/25 mg
Last review date of this leaflet: March 2022
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.